IGF-I stimulates muscle glucose uptake during sepsis

Shock

Volumn 5, Issue 1, 1996, Pages 22-27

  Lang, Charles H ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN C;

ANIMAL; ARTICLE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MUSCLE; RAT; SEPSIS; SPRAGUE DAWLEY RAT;

ANIMALS; GLUCOSE; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLES; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 0029680553     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199601000-00006     Document Type: Article

References (37)

1. Lang CH: Mechanism of insulin resistance in infection. In Schlag G and Redl H (eds): Pathophysiology of Shock, Sepsis, and Organ Failure. New York: Springer-Verlag, 1993, pp 593-608.
2. Virkamaki A, Yki-Jarvinen H: Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134:2072-2078, 1994.
3. Thorell A, Efendic S, Gutniak M, Haggmark T, Ljungqvist O: Insulin resistance after abdominal surgery. Br J Surg 81:59-63, 1994.
4. Lang CH: Sepsis-induced insulin resistance in rats is mediated by a β-adrenergic mechanism. Am J Physiol 262:E703-E711, 1992.
5. Lang CH, Dobrescu C, Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52, 1992.
6. Virkamaki A, Puhakainen I, Koivisto VA, Vuorinen-Markkol H, YkiJarvinen H: Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans. J Clin Endocrinol Metab 74:673-679, 1992.
7. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DA, Wolfe RR: Differentiation between septic and postbum insulin resistance. Metabolism 38:983-989, 1989.
8. Chaudry IH, Sayeed MM, Baue AE: The effect of insulin on glucose uptake in soleus muscle during hemorrhage shock. Can J Physiol Pharmacol 53:67-73, 1975.
9. Vary TC, Drnevich D, Jurasinski C, Brennan WA: Mechanisms regulating skeletal muscle glucose metabolism in sepsis. Shock 3:403-410, 1995.
10. Rotwein P: Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5:3-18, 1991.
11. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev 16:143-162, 1995.
12. Elahi D, McAloon-Dyke M, Fukagawa NK, Sclater AL, Wong GA, Shannon RP, Minaker KL, Miles JM, Rubenstein AH, Vandepol CJ, Guler H-P, Good WR, Seaman JJ, Wolfe RR: Effects of recombinant human IGF-I on glucose and leucine kinetics in men. Am J Physiol 265:E831E838, 1993.
13. Cascieri MA, Slater EE, Vicario PP, Green BG, Bayne ML, Saperstein R: Impaired insulin-like growth factor-I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse. Diabetologia 32:342-347, 1989.
14. Dardevet D, Somet C, Attaix D, Baracos VE, Grizard J: Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats. Endocrinology 134:1475-1484, 1994.
15. Dimitriadis G, Parry-Billings M, Bevan S, Dunger D, Piva T, Krause U, Wegener G, Newsholme EA: Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J 285:269-274, 1992.
16. Rossetti L, Frontoni S, Dimarchi R, DeFronzo RA, Giaccari A: Metabolic effects of IGF-I in diabetic rats. Diabetes 40:444-448, 1991.
17. Jacob RJ, Sherwin RS, Bowen L, Fryburg D, Fagin KD, Tamborlane WV, Shulman GI: Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol 260:E262-E268, 1991.
18. Poggi C, Marchand-Brustel Y, Zapf J, Froesch ER, Freychet P: Effects of binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: Comparison with insulin. Endocrinology 105:723-729, 1979.
19. Dohm GL, Elton CW, Raju MS, Mooney ND, DiMarchi R, Pories WJ, Flickinger EG, Atkinson SM, Caro JF: IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes 39:1028-1032, 1990.
20. Lang CH, Dobrescu C, Meszaros K: Insulin-mediated glucose utilization of individual tissues during sepsis. Metabolism 39:1096-1107, 1990.
21. Lang CH, Dobrescu C: Gram-negative infection increases noninsulinmediated glucose disposal. Endocrinology 128:645-653, 1991.
22. Rossetti L, Giaccari A: Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake: A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85:1785-1792, 1990.
23. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemia-euglycemic glucose clamps. Diabetes 36:914-924, 1987.
24. Butler P, Bell P, Rizza R: Choice and use of tracers. Harm Metab Res 24(Suppl):20-25, 1990.
25. Keepler D, Decker K: Glycogen determination with amyloglucosidase. In Bergmeyer HU (ed): Methods of Enzymatic Analysis, New York: Academic Press, 1974, pp 1127-1131.
26. Fan J, Molina PE, Gelato MC, Lang CH: Differential tissue regulation of insulin-like growth factor I content and binding proteins after endotoxin. Endocrinology 134:1685-1692, 1994.
27. Yik-Jarvinen H, Sammalkorpi K, Koivisto VA, Nikkila EA: Severity, duration and mechanisms of insulin resistance during acute infections. J Clin Endocrinol Metab 69:317-323, 1989.
28. Zenni GC, McLane MP, Law WR, Raymond RM: Hepatic insulin resistance during chronic hyperdynamic sepsis. Circ Shock 37:198-208, 1992.
29. Jurasinski CV, Vary TC: Insulin-like growth factor-I accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol 1995. In press.
30. Baron AD, Brechtel P, Edelman SV: Rates and tissue sties of non-insulinand insulin-mediated glucose uptake in humans. Am J Physiol 255:E769E774, 1988.
31. Baxter RC: Insulin-like growth factor (IGF) binding proteins: The role of serum IGFBPs in regulating IGF availability. Acta Pediatr Scand 372(Suppl):107-114, 1991.
32. Fan J, Li YH, Bagby GJ, Lang CH: Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody. Shock 4:21-26, 1995.
33. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH: Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol 268: R970-R977, 1955.
34. Fan J, Char D, Kolasa AJ, Pan W, Maitra SR, Patlak CS, Spolarics Z, Gelato MC, Lang CH: Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. Am J Physiol 269:E33-E42, 1995.
35. Massague J, Czech MP: The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 257:5038-5045, 1982.
36. Jacob R, Barrett E, Plewe G, Fagin KD, Sherwin RS: Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. J Clin Invest 83:1717-1723, 1989.
37. Leahy JL, Vandekerkhove KM: Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126:1593-1598, 1990.